Congenital macroglossia

Congenital macroglossia is a rare condition present at birth characterized by an abnormally enlarged tongue (macroglossia) that is disproportionate to the size of the oral cavity. The tongue enlargement may be due to muscular hypertrophy, vascular malformations, lymphatic malformations, or other tissue overgrowth within the tongue. This condition can occur as an isolated finding or as a feature of various syndromes, including Beckwith-Wiedemann syndrome, Down syndrome, mucopolysaccharidoses, and congenital hypothyroidism. When classified under Orphanet code 2430, it refers specifically to isolated congenital macroglossia not associated with a broader syndromic condition. The enlarged tongue can significantly affect multiple body functions. Affected infants may experience difficulties with feeding and swallowing, airway obstruction, drooling, speech difficulties as they grow older, and dental or orthodontic problems including open bite and mandibular prognathism. In severe cases, the tongue may protrude from the mouth, leading to drying, ulceration, and potential infection of the exposed tissue. Breathing difficulties, particularly during sleep (obstructive sleep apnea), can also occur and may pose serious health risks if left untreated. Management of congenital macroglossia depends on the severity of the condition and its underlying cause. Mild cases may be monitored conservatively with supportive care, including speech therapy and orthodontic management. In more severe cases where feeding difficulties, airway compromise, or significant functional impairment are present, surgical reduction of the tongue (glossectomy or tongue reduction surgery) may be necessary. Early evaluation by a multidisciplinary team including pediatricians, otolaryngologists, oral and maxillofacial surgeons, speech therapists, and geneticists is recommended to optimize outcomes.

Common questions about Congenital macroglossia